388 related articles for article (PubMed ID: 1279332)
1. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.
Horak ER; Leek R; Klenk N; LeJeune S; Smith K; Stuart N; Greenall M; Stepniewska K; Harris AL
Lancet; 1992 Nov; 340(8828):1120-4. PubMed ID: 1279332
[TBL] [Abstract][Full Text] [Related]
2. [The importance of tumor angiogenesis as a prognostic indicator in primary breast cancer].
Saji S; Toi M; Tominaga T
Nihon Geka Gakkai Zasshi; 1996 May; 97(5):368-74. PubMed ID: 8709939
[TBL] [Abstract][Full Text] [Related]
3. Expression of platelet-endothelial cell adhesion molecule-1 (PECAM-1) during melanoma-induced angiogenesis in vivo.
Berger R; Albelda SM; Berd D; Ioffreda M; Whitaker D; Murphy GF
J Cutan Pathol; 1993 Oct; 20(5):399-406. PubMed ID: 7507944
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.
Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ
APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465
[TBL] [Abstract][Full Text] [Related]
5. Tumor angiogenesis in node-negative breast carcinomas--relationship with epidermal growth factor receptor, estrogen receptor, and survival.
Fox SB; Leek RD; Smith K; Hollyer J; Greenall M; Harris AL
Breast Cancer Res Treat; 1994 Jan; 29(1):109-16. PubMed ID: 7517221
[TBL] [Abstract][Full Text] [Related]
6. Tumor Angiogenesis in Breast Cancer: Pericytes and Maturation Does Not Correlate With Lymph Node Metastasis and Molecular Subtypes.
Shrivastav S; Bal A; Singh G; Joshi K
Clin Breast Cancer; 2016 Apr; 16(2):131-8. PubMed ID: 26452314
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients.
Gasparini G; Toi M; Verderio P; Ranieri G; Dante S; Bonoldi E; Boracchi P; Fanelli M; Tominaga T
Int J Oncol; 1998 May; 12(5):1117-25. PubMed ID: 9538138
[TBL] [Abstract][Full Text] [Related]
8. Assessing microvessels and angiogenesis in human breast cancer, using VE-cadherin.
Martin TA; Watkins G; Lane J; Jiang WG
Histopathology; 2005 Apr; 46(4):422-30. PubMed ID: 15810954
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer.
Van den Eynden GG; Van der Auwera I; Van Laere SJ; Colpaert CG; Turley H; Harris AL; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
Br J Cancer; 2005 Nov; 93(10):1128-36. PubMed ID: 16251878
[TBL] [Abstract][Full Text] [Related]
10. Correlation between tumor angiogenesis and metastasis in breast cancer.
Chu JS; Lee WJ; Chang TC; Chang KJ; Hsu HC
J Formos Med Assoc; 1995 Jul; 94(7):373-8. PubMed ID: 7549559
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer.
Heimann R; Ferguson D; Powers C; Recant WM; Weichselbaum RR; Hellman S
J Natl Cancer Inst; 1996 Dec; 88(23):1764-9. PubMed ID: 8944007
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.
Dales JP; Garcia S; Andrac L; Carpentier S; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C
Int J Oncol; 2004 May; 24(5):1197-204. PubMed ID: 15067342
[TBL] [Abstract][Full Text] [Related]
14. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.
Gasparini G; Weidner N; Bevilacqua P; Maluta S; Dalla Palma P; Caffo O; Barbareschi M; Boracchi P; Marubini E; Pozza F
J Clin Oncol; 1994 Mar; 12(3):454-66. PubMed ID: 7509851
[TBL] [Abstract][Full Text] [Related]
15. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma.
Toi M; Kashitani J; Tominaga T
Int J Cancer; 1993 Sep; 55(3):371-4. PubMed ID: 7690738
[TBL] [Abstract][Full Text] [Related]
16. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.
Axelsson K; Ljung BM; Moore DH; Thor AD; Chew KL; Edgerton SM; Smith HS; Mayall BH
J Natl Cancer Inst; 1995 Jul; 87(13):997-1008. PubMed ID: 7543156
[TBL] [Abstract][Full Text] [Related]
17. Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39.
Kakolyris S; Fox SB; Koukourakis M; Giatromanolaki A; Brown N; Leek RD; Taylor M; Leigh IM; Gatter KC; Harris AL
Br J Cancer; 2000 Feb; 82(4):844-51. PubMed ID: 10732757
[TBL] [Abstract][Full Text] [Related]
18. [The immunohistochemical expression of CD105 is a marker for high metastatic risk and worse prognosis in breast cancers].
Charpin-Taranger C; Dales JP; Garcia S; Andrac-Meyer L; Ramuz O; Carpentier-Meunier S; Bonnier P
Bull Acad Natl Med; 2003; 187(6):1129-45; discussion 1145-6. PubMed ID: 14978873
[TBL] [Abstract][Full Text] [Related]
19. VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis.
Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
J Pathol; 2001 Mar; 193(3):325-32. PubMed ID: 11241411
[TBL] [Abstract][Full Text] [Related]
20. CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma.
Schlüter A; Weller P; Kanaan O; Nel I; Heusgen L; Höing B; Haßkamp P; Zander S; Mandapathil M; Dominas N; Arnolds J; Stuck BA; Lang S; Bankfalvi A; Brandau S
BMC Cancer; 2018 Mar; 18(1):272. PubMed ID: 29523110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
